What are the PK/PD properties for GLP-1 RAs and how do these differences affect their clinical roles? And specifically, how do long- vs. short-acting GLP-1 RAs affect PPG vs FPG?

What are the PK/PD properties for GLP-1 RAs and how do these differences affect their clinical roles? And specifically, how do long- vs. short-acting GLP-1 RAs affect PPG vs FPG?

What are the PK/PD properties for GLP-1 RAs and how do these differences affect their clinical roles? And specifically, how do long- vs. short-acting GLP-1 RAs affect PPG vs FPG?

CLICK HERE FOR CME CREDIT

Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Filip Knop, MD

Filip Knop, MD

Diabetes Research Division
Department of Internal Medicine
Gentofte University Hospital
Copenhagen, Denmark